Skip to contentV
Vycor Medical Inc
V
VYCOVycor Medical Inc Q4 2016 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$347.45K$347.45Kderived+23.6% vs Q4 2015 Net Income-$487.46K-$487.46KderivedN/M vs Q4 2015 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$315,601+37.8% Operating Incomederived-$469,874N/M Operating Cash Flowderived-$111,244N/M Free Cash Flowderived-$140,431N/M Margins · derivedGross margin90.8%+9.4 pt vs Q4 2015
Operating margin-135.2%+12.5 pt vs Q4 2015
Net margin-140.3%+13.1 pt vs Q4 2015
ended Dec 31, 2016 · filed Mar 31, 2017 · 90 d after period end